Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products

Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding

Denosumab treatment is associated with the absence of circulating tumor cells in patients with breast cancer

A novel workflow to enrich and isolate patient-matched EpCAM high and EpCAM low/negative CTCs enables the comparative characterization of the PIK3CA status in metastatic breast cancer

A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells

Request a meeting with